Bank of Communications (SHA:601328, HKG:3328) completed the issuance of 40 billion yuan of its tier 1 capital bonds on Monday, according to a Tuesday filing with the Shanghai Stock Exchange.
The bonds have a coupon of 1.94% for the first five years, adjustable every five years, with a conditional redemption option on each interest payment date from year 5 onwards, the bank said.
Atlas Arteria's (ASX:ALX) independent directors urged its security holders in its target's statement to reject an unsolicited off-market cash takeover offer by Diamond Infraco 1, a wholly-owned unit of IFM Global Infrastructure Fund, saying "it is opportunistic and materially undervalues Atlas Arteria," according to a Tuesday Australian bourse filing.The directors' view was reinforced by the opinion of an independent expert, who concluded that the offer is neither fair nor reasonable.The target's statement was sent to Diamond Infraco and lodged with the Australian Securities and Investments Commission on Tuesday. The bidder offered the security holders AU$4.75 in cash per ALX Atlas Arteria security, less any distributions paid by the firm.Diamond Infraco expressed "strong disagreement" with the arguments brought forth by the independent directors of Atlas Arteria to support their recommendation that Atlas Arteria security holders reject the offer, according to its second supplementary bidder's statement.It confirmed that the EU merger control regulatory approval condition, as stated in the bidder's statement, was satisfied.
GoFintech Innovation (HKG:0290) agreed to invest around $40 million in a Hong Kong-based decentralized social and messaging platform operator, according to a filing with the city's bourse Tuesday.The firm will purchase around 11.9 million Luffa AI shares from three existing investors for $19.8 million, and subscribe to a further 10 million shares of the business under a separate transaction.The shares collectively represent 19.9% of Luffa AI's enlarged share capital.GoFintech Innovation had announced its intention to invest in Luffa AI in April.
Nanosonics (ASX:NAN) advanced the staged rollout of its CORIS system by submitting a second application to the US food and drug administration aimed at broadening approved endoscope indications following its earlier clearance, according to a Tuesday filing with the Australian bourseThe company is also progressing its controlled market release (CMR) program, having installed its first CORIS unit in Australia and started staff training in preparation for a planned rollout, per the filing.The United Kingdom CMR is ongoing and performing as expected, with Australia and Ireland sites rolling out next and US activities to follow based on early learnings, the filing added.